2021 American Transplant Congress Archives - Page 2 of 139

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

4:35pm-4:40pm: Adult Combined Liver-Heart Transplantation: The United States Experience

I. A. Ziogas¹, S. P. Alexopoulos¹, W. K. Wu¹, L. K. Matsuoka¹, M. A. Rauf¹, M. Izzy², R. Perri², K. H. Schlendorf³, J. N. Menachem³, A. S. Shah⁴

Heart: Triple "D" in Heart Transplantation: DCD, Dual-Organ and Declined Hearts • Virtual

4:35pm-4:40pm: Allocating Kidneys in Optimized Circles: Logistics are More Important Than Distance

R. Saidi, R. Shahbazov, M. Hanlon, M. laftavi

Kidney Deceased Donor Allocation • Virtual

4:35pm-4:40pm: Immunosuppression in Uterine Transplant Recipients: Experience from the Largest Uterine Transplant Program

N. Wilson, R. Patel, L. Johannesson, G. Testa, T. Sam

VCA: Basic and Clinical • Virtual

4:35pm-4:40pm: Impact of Advanced Renal Dysfunction on Post-Transplant Outcomes After Living Donor Liver Transplantation in the United States

T. Bittermann¹, N. Kaur², P. L. Abt¹, K. M. Olthoff¹, J. K. Heimbach³, J. Emamaullee²

Living Donor Liver Transplant and Partial Grafts • Virtual

4:35pm-4:40pm: Systematic Screening of Kidney Transplant Patients Points Towards Deficits in Neutralizing Antibody Capacity Against Sars-cov-2

V. Wijtvliet¹, K. K. Ariën², J. Mariën², B. Peeters³, R. Hellemans⁴, A. Massart⁴, S. Van Hees¹, P. Moons⁵, H. Theeten⁶, P. Van Damme⁶, H. Goossens⁷, B. Y. De Winter¹, K. J. Ledeganck¹, D. Abramowicz⁴

COVID-19 Session 1 • Virtual

4:35pm-4:40pm: T-cell-Mediated Immunity to Sars-cov-2 Defines Covid-19 Risk and Severity in Transplanted and Non-Transplanted Individuals and Associates with Myeloid-Derived Suppressor Cells

C. Ashokkumar¹, V. Rohan², A. H. Kroemer³, S. Rao⁴, G. Mazariegos⁵, B. W. Higgs⁵, S. Nadig², M. Ningappa⁵, T. Fishbein³, S. Subramaniam⁶, R. Sindhi⁷

Biomarkers, Immune Assessment and Clinical Outcomes - I • Virtual

4:40pm-4:45pm: A Multi-institutional Study of Renal Outcomes in Uterus Transplantation

D. Sawinski¹, L. Johannesson², J. Kristen³, J. Fronek³, P. Porrett⁴

VCA: Basic and Clinical • Virtual

4:40pm-4:45pm: Clinical Outcomes of Solid Organ Transplant Recipients Treated with Remdesivir and Convalescent Plasma for Covid-19 at the Largest Transplant Center in the United States

A. Fernandez, S. Anjan, A. Chandorkar, D. de Lima, R. Zamora, L. A. Mendez-Castaner, J. Simkins, J. Camargo, M. Morris, M. Loebe, J. Bauerlein, C. O’Brien, N. Sinha, G. Burke, G. Ciancio, A. Mattiazzi, R. Vianna, L. Abbo, G. Guerra, Y. Natori

COVID-19 Session 1 • Virtual

4:40pm-4:45pm: High Degree of Center Variation in Simultaneous Heart Kidney Transplant: Opportunities for Standardization

B. I. Shaw¹, M. L. Samoylova¹, S. J. Kesseli¹, D. Olaso², A. S. Barbas¹, D. L. Sudan¹, L. E. Boulware³, L. M. McElroy¹

Heart: Triple "D" in Heart Transplantation: DCD, Dual-Organ and Declined Hearts • Virtual

4:40pm-4:45pm: Impact of Community- Targeted Educational Campaign on Living Donor Transplants

S. Ganesh, A. Humar

Living Donor Liver Transplant and Partial Grafts • Virtual